{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:11:09Z","timestamp":1790640669609,"version":"4.1.0"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.tmrv.2007.01.001","type":"journal-article","created":{"date-parts":[[2007,3,29]],"date-time":"2007-03-29T07:17:53Z","timestamp":1175152673000},"page":"S9-S56","source":"Crossref","is-referenced-by-count":142,"special_numbering":"S1","title":["Guidelines on the Use of Intravenous Immune Globulin for Hematologic Conditions"],"prefix":"10.1016","volume":"21","author":[{"given":"David","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiser","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Blanchette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Couban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Radmoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Huebsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Hume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Moltzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Nahirniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Nantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Pineo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Rock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2007.01.001_bib1","unstructured":"Feasby TE: Appropriateness of IVIG\u2014hematology summaries (unpublished)."},{"key":"10.1016\/j.tmrv.2007.01.001_bib2","series-title":"A systematic literature review and report on the efficacy of intravenous immunoglobulin therapy and its risks. Final Report v04","author":"Biotext Science Information Consultants","year":"2004"},{"key":"10.1016\/j.tmrv.2007.01.001_bib3","unstructured":"Chalmers Research Institute: IVIG systematic reviews. (unpublished)"},{"key":"10.1016\/j.tmrv.2007.01.001_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0887-7963(03)00038-5","article-title":"Risks associated with the use of intravenous immunoglobulin","volume":"17","author":"Pierce","year":"2003","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2007.01.001_bib5","author":"Phillips"},{"key":"10.1016\/j.tmrv.2007.01.001_bib6","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1200\/JCO.1998.16.3.1226","article-title":"Progress of clinical oncology guidelines development using the practice guidelines development cycle: The role of practitioner feedback","volume":"16","author":"Browman","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.1365-2141.1996.d01-1965.x","article-title":"Low response to high-dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitor","volume":"95","author":"Crenier","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1365-2516.2001.00489.x","article-title":"Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: A 2-year review","volume":"7","author":"Dykes","year":"2001","journal-title":"Haemophilia"},{"key":"10.1016\/j.tmrv.2007.01.001_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2257.1995.tb00322.x","article-title":"Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia","volume":"17","author":"Boughton","year":"1995","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib10","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1056\/NEJM198810063191403","article-title":"Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2007.01.001_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2141.1994.tb05002.x","article-title":"Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: A comparison of 2 dose regimes","volume":"88","author":"Chapel","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib12","first-page":"17","article-title":"Intravenous immune globulin in chronic lymphocytic leukaemia","volume":"97","author":"Gamm","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/blood.V73.2.366.366","article-title":"Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors","volume":"73","author":"Griffiths","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.01.001_bib14","first-page":"121","article-title":"Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study","volume":"81","author":"Molica","year":"1996","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2007.01.001_bib15","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(94)90180-5","article-title":"Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma","volume":"343","author":"Chapel","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2007.01.001_bib16","first-page":"261","article-title":"Infection, immune responses and IV immunoglobulin infection prophylaxis in myeloma","volume":"66","author":"Hargreaves","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1016\/j.tmrv.2007.01.001_bib17","first-page":"254","article-title":"Intravenous immunoglobulin replacement in secondary antibody deficiency syndrome","volume":"7","author":"Schedel","year":"1982","journal-title":"Diagn Intensivther"},{"key":"10.1016\/j.tmrv.2007.01.001_bib18","first-page":"52","article-title":"Intravenous immunoglobulin in the treatment of infections in children with acute leukemias","volume":"47","author":"Gebauer","year":"1994","journal-title":"Med Pregl"},{"key":"10.1016\/j.tmrv.2007.01.001_bib19","first-page":"115","article-title":"Immunoglobulin prophylaxis during intensive treatment of acute lymphoblastic leukemia in children","volume":"32","author":"Gimesi","year":"1992","journal-title":"Acta Paediatr Hung"},{"key":"10.1016\/j.tmrv.2007.01.001_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF00595896","article-title":"Treatment of fever and neutropenia with antibiotics versus antibiotics plus intravenous gammaglobulin in childhood leukemia","volume":"148","author":"Sumer","year":"1989","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.tmrv.2007.01.001_bib21","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1365-2141.2002.03741.x","article-title":"Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin","volume":"118","author":"Hayakawa","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib22","first-page":"106","article-title":"Pure red cell aplasia: Treatment with intravenous immunoglobulin concentrate","volume":"29","author":"Ballester","year":"1992","journal-title":"Semin Hematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib23","first-page":"1079","article-title":"Erythroblastopenia: Chronic idiopathic or associated with chronic lymphoid leukemia. Value of cultures of erythroblastic progenitors and therapeutic strategy","volume":"22","author":"Casadevall","year":"1993","journal-title":"Presse Med"},{"key":"10.1016\/j.tmrv.2007.01.001_bib24","first-page":"47","article-title":"Relapsing pure red cell aplasia associated with B-cell chronic lymphocytic leukemia successfully treated by intravenous immunoglobulin concentrate","volume":"17","author":"Castelli","year":"2002","journal-title":"Ann Ital Med Int"},{"key":"10.1016\/j.tmrv.2007.01.001_bib25","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2141.1983.tb01260.x","article-title":"Treatment of pure red cell aplasia by high dose intravenous immunoglobulins","volume":"55","author":"Clauvel","year":"1983","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1365-2141.2001.02693.x","article-title":"Pure red cell aplasia associated with small lymphocytic lymphoma","volume":"113","author":"Cobcroft","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000204509","article-title":"Pure red cell aplasia associated with systemic lupus erythematosus: Remission after a single course of intravenous immunoglobulin","volume":"89","author":"Ilan","year":"1993","journal-title":"Acta Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF01451021","article-title":"Successfully treated sulphasalazine-induced fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia with intravenous immunoglobulin","volume":"17","author":"Huang","year":"1998","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1034\/j.1600-0609.2000.9c212.x","article-title":"Successful treatment of thymoma-associated pure red cell aplasia with intravenous immunoglobulins","volume":"65","author":"Larroche","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2796.1994.tb00851.x","article-title":"Chronic idiopathic pure red cell aplasia: Successful treatment during pregnancy and durable response to intravenous immunoglobulin","volume":"236","author":"Mant","year":"1994","journal-title":"J Intern Med"},{"key":"10.1016\/j.tmrv.2007.01.001_bib31","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM198710153171606","article-title":"Treatment of antibody-mediated pure red-cell aplasia with high-dose intravenous gamma globulin","volume":"317","author":"McGuire","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2007.01.001_bib32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ajh.2830320216","article-title":"Durable remission of pure red cell aplasia after treatment with high-dose intravenous gammaglobulin and prednisone","volume":"32","author":"Needleman","year":"1989","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib33","first-page":"335","article-title":"Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team","volume":"13","author":"Ohashi","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2007.01.001_bib34","first-page":"471","article-title":"Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin","volume":"16","author":"Roychowdhury","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2007.01.001_bib35","first-page":"71","article-title":"Spontaneous recovery from severe parvovirus B19 pure red cell aplasia, in a heart transplant recipient, as demonstrated by marrow culture","volume":"40","author":"Amiot","year":"1998","journal-title":"Hematol Cell Ther"},{"key":"10.1016\/j.tmrv.2007.01.001_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s002770050315","article-title":"Red cell aplasia caused by parvovirus B19 in AIDS: Use of I.V. immunoglobulin","volume":"75","author":"Koduri","year":"1997","journal-title":"Ann Hematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<16::AID-AJH4>3.0.CO;2-Y","article-title":"Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: Use of intravenous immunoglobulin\u2014a report of 8 patients","volume":"61","author":"Koduri","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib38","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1080\/10428190127513","article-title":"Pure red cell aplasia associated with parvovirus B19 infection in T-large granular lymphocyte leukemia","volume":"42","author":"Kondo","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.tmrv.2007.01.001_bib39","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0272-6386(99)70021-1","article-title":"Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus","volume":"34","author":"Wong","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.tmrv.2007.01.001_bib40","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/blood.V92.8.2707","article-title":"Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: Comparison of 3 different therapeutic approaches","volume":"92","author":"Federici","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.01.001_bib41","first-page":"843","article-title":"Transient aplastic anemia caused by parvovirus B19 infection in a heart transplant recipient","volume":"15","author":"Bergen","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tmrv.2007.01.001_bib42","first-page":"672","article-title":"Aplastic anemia. Report of a case with recurrent episodes in consecutive pregnancies","volume":"42","author":"Bourantas","year":"1997","journal-title":"J Reprod Med"},{"key":"10.1016\/j.tmrv.2007.01.001_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ajh.2830490213","article-title":"Treatment of platelet alloimmunization with intravenous immunoglobulin in a child with aplastic anemia","volume":"49","author":"Chen","year":"1995","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2141.1995.tb03302.x","article-title":"Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis","volume":"89","author":"Chen","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2141.1988.tb07610.x","article-title":"High dose intravenous gammaglobulin as an approach to treatment of antibody mediated pancytopenia","volume":"69","author":"Kapoor","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib46","first-page":"237","article-title":"Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anaemia","volume":"18","author":"De Lord","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2007.01.001_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01703116","article-title":"Use of intravenous immunoglobulins (IVIg) to treat a child with pancytopenia and hypoplastic marrow","volume":"65","author":"Lutz","year":"1992","journal-title":"Ann Hematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib48","first-page":"689","article-title":"Chicken pox induced pancytopenia and prompt response to high dose intravenous immunoglobulin","volume":"40","author":"Salim","year":"1992","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.tmrv.2007.01.001_bib49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0953-6205(00)00067-4","article-title":"Treatment of hematologic disorders other than immune thrombocytopenic purpura with intravenous immunoglobulin (IVIg)\u2014report of 7 cases and review of the literature","volume":"11","author":"Sherer","year":"2000","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.tmrv.2007.01.001_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ajh.2830440404","article-title":"Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: Results in 73 patients","volume":"44","author":"Flores","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib51","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1182\/blood.V62.2.398.398","article-title":"Reversal of neutropenia with intravenous gammaglobulin in autoimmune neutropenia of infancy","volume":"62","author":"Bussel","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.01.001_bib52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0022-3476(88)80074-X","article-title":"Intravenous treatment with gamma-globulin of autoimmune neutropenia of infancy","volume":"112","author":"Bussel","year":"1988","journal-title":"J Pediatr"},{"key":"10.1016\/j.tmrv.2007.01.001_bib53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V91.1.181","article-title":"Diagnosis and clinical course of autoimmune neutropenia in infancy: Analysis of 240 cases","volume":"91","author":"Bux","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.01.001_bib54","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00043426-199122000-00011","article-title":"Autoimmune neutropenia and Hodgkin's disease: Successful treatment with intravenous gammaglobulin","volume":"13","author":"Gordon","year":"1991","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib55","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9343(87)90547-X","article-title":"Use of intravenous gamma globulin for the treatment of autoimmune neutropenia of childhood and autoimmune hemolytic anemia","volume":"83","author":"Hilgartner","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.tmrv.2007.01.001_bib56","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1651-2227.1993.tb12625.x","article-title":"Anti-Rh(D) immunoglobulin for autoimmune neutropenia of infancy","volume":"82","author":"Mascarin","year":"1993","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.tmrv.2007.01.001_bib57","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jca.2920040212","article-title":"Clinical uses of intravenous immune globulin: Immunoglobulin replacement therapy and treatment of autoimmune cytopenias","volume":"4","author":"Sorensen","year":"1988","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.tmrv.2007.01.001_bib58","first-page":"371","article-title":"Autoimmune cytopenias associated with malignancies and successfully treated with intravenous immune globulins: About two cases","volume":"55","author":"Alliot","year":"2000","journal-title":"Therapie"},{"key":"10.1016\/j.tmrv.2007.01.001_bib59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000203968","article-title":"Immunoglobulin therapy for autoimmune neutropenia in Hodgkin's disease","volume":"94","author":"Schoengen","year":"1995","journal-title":"Acta Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1182\/asheducation-2000.1.18","article-title":"New insights into the pathophysiology of acquired cytopenias","author":"Young","year":"2000","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1016\/j.tmrv.2007.01.001_bib61","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00043426-199511000-00003","article-title":"Evans syndrome. Results of a pilot study utilizing a multiagent treatment protocol","volume":"17","author":"Scaradavou","year":"1995","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00043426-199709000-00005","article-title":"Evans syndrome: Results of a national survey","volume":"19","author":"Mathew","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib63","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1442-200x.1999.01004.x","article-title":"Treatment of refractory Evans' syndrome with cyclosporine and prednisone","volume":"41","author":"Ucar","year":"1999","journal-title":"Pediatr Int"},{"key":"10.1016\/j.tmrv.2007.01.001_bib64","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00043426-199905000-00016","article-title":"Evans syndrome: Successful management with multi-agent treatment including intermediate-dose intravenous cyclophosphamide","volume":"21","author":"Gombakis","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s100670170107","article-title":"Induction of remission with intravenous immunoglobulin and cyclophosphamide in steroid-resistant Evans' syndrome associated with dermatomyositis","volume":"20","author":"Chang","year":"2001","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib66","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1442-200X.2001.01429.x","article-title":"Treatment-resistant infantile Evans syndrome","volume":"43","author":"Muwakkit","year":"2001","journal-title":"Pediatr Int"},{"key":"10.1016\/j.tmrv.2007.01.001_bib67","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00043426-200304000-00019","article-title":"Report of a child with vitiligo and Evans syndrome","volume":"25","author":"Muwakkit","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib68","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF00422936","article-title":"Autoimmune hemolytic anemia combined with idiopathic thrombocytopenia (Evans syndrome). Sustained remission in a patient following high-dose intravenous gamma-globulin therapy","volume":"70","author":"Petrides","year":"1992","journal-title":"Clin Investig"},{"key":"10.1016\/j.tmrv.2007.01.001_bib69","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00043426-199809000-00020","article-title":"Fatal autoimmune hemolytic anemia in a child due to warm-reactive immunoglobulin M antibody","volume":"20","author":"Friedmann","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib70","first-page":"321","article-title":"Intravenous immunoglobulin G therapy in Evans syndrome","volume":"50","author":"Qureshi","year":"2000","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.tmrv.2007.01.001_bib71","first-page":"186","article-title":"High dose intravenous immunoglobulin (IVIgG) in Evans' syndrome","volume":"19","author":"Bolis","year":"1991","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.tmrv.2007.01.001_bib72","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2141.1998.00533.x","article-title":"Feto-maternal alloimmune thrombocytopenia: Antenatal therapy with IvIgG and steroids\u2014more questions than answers","volume":"100","author":"Kaplan","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib73","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1067\/mob.2001.117668","article-title":"Initial fetal platelet counts predict the response to intravenous gammaglobulin therapy in fetuses that are affected by PLA1 incompatibility","volume":"185","author":"Gaddipati","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib74","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/(SICI)1097-0223(199606)16:6<495::AID-PD899>3.0.CO;2-Y","article-title":"Therapy with intravenous immunoglobulin G (ivIgG) during pregnancy for fetal alloimmune (HPA-1a(Zwa)) thrombocytopenic purpura","volume":"16","author":"Giers","year":"1996","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.tmrv.2007.01.001_bib75","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1067\/mob.2000.104841","article-title":"Neonatal alloimmune thrombocytopenia: Antenatal management","volume":"182","author":"Silver","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib76","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000264304","article-title":"Antenatal invasive and noninvasive management of alloimmune thrombocytopenia","volume":"11","author":"Kornfeld","year":"1996","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.tmrv.2007.01.001_bib77","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0002-9378(96)70582-3","article-title":"Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: A randomized trial of the addition of low-dose steroid to intravenous gamma-globulin","volume":"174","author":"Bussel","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib78","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2141.2003.04408.x","article-title":"European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia","volume":"122","author":"Birchall","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib79","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-139-1-200307010-00007","article-title":"Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial","volume":"139","author":"Cordonnier","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmrv.2007.01.001_bib80","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.bmt.1701742","article-title":"Comparison of two doses of intravenous immunoglobulin after allogeneic bone marrow transplants","volume":"23","author":"Abdel-Mageed","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2007.01.001_bib81","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1083-8791(99)70013-3","article-title":"Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts","volume":"5","author":"Feinstein","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tmrv.2007.01.001_bib82","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.bmt.1703109","article-title":"A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation","volume":"28","author":"Winston","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2007.01.001_bib83","first-page":"283","article-title":"Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients","volume":"12","author":"Winston","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2007.01.001_bib84","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-106-1-12","article-title":"Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation","volume":"106","author":"Winston","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmrv.2007.01.001_bib85","first-page":"132","article-title":"A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT)","volume":"83","author":"Zikos","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2007.01.001_bib86","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.bmt.1700649","article-title":"No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group","volume":"19","author":"Ruutu","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2007.01.001_bib87","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/infdis\/164.3.483","article-title":"Cytomegalovirus (CMV)-specific intravenous immunoglobulin for the prevention of primary CMV infection and disease after marrow transplant","volume":"164","author":"Bowden","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2007.01.001_bib88","first-page":"680","article-title":"Intravenous gamma-globulin (IVIG) does not alter immune parameters in a randomized trial after bone-marrow transplantation (BMT)","volume":"22","author":"Lum","year":"1994","journal-title":"Exp Hematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib89","first-page":"132","article-title":"Preventing systemic infections with IVIG: A randomized multicenter trial","volume":"5","author":"Pole","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2007.01.001_bib90","first-page":"451","article-title":"Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation","volume":"9","author":"Poynton","year":"1992","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.tmrv.2007.01.001_bib91","first-page":"44","article-title":"A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: Clinical outcome and effect on subsequent immune recovery","volume":"2","author":"Sullivan","year":"1996","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tmrv.2007.01.001_bib92","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJM199009133231103","article-title":"Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation","volume":"323","author":"Sullivan","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2007.01.001_bib93","doi-asserted-by":"crossref","first-page":"937","DOI":"10.7326\/0003-4819-118-12-199306150-00004","article-title":"High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group","volume":"118","author":"Wolff","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmrv.2007.01.001_bib93a","first-page":"S202","article-title":"Antimicrobial prophylaxis in EBMT centers : A report from the Infectious Diseases Working Party.","volume":"27","author":"Aldan","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2007.01.001_bib94","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.114.1.297","article-title":"Subcommittee on hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation","volume":"114","author":"American Academy of Pediatrics","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.tmrv.2007.01.001_bib95","doi-asserted-by":"crossref","first-page":"F6","DOI":"10.1136\/fn.88.1.F6","article-title":"Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn","volume":"88","author":"Gottstein","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.tmrv.2007.01.001_bib96","first-page":"CD003313","article-title":"Systematic review: Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates","author":"Alcock","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2007.01.001_bib97","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1651-2227.1999.tb01085.x","article-title":"High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice","volume":"88","author":"Alpay","year":"1999","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.tmrv.2007.01.001_bib98","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/030006059502300406","article-title":"High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease","volume":"23","author":"Dagoglu","year":"1995","journal-title":"J Int Med Res"},{"key":"10.1016\/j.tmrv.2007.01.001_bib99","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-3476(05)82551-X","article-title":"High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease","volume":"121","author":"Rubo","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.tmrv.2007.01.001_bib100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2257.1993.tb00122.x","article-title":"Haemolytic transfusion reaction\u2014Successful attenuation with methylprednisolone and high dose immunoglobulin","volume":"15","author":"Woodcock","year":"1993","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib101","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1423-0410.1994.tb01659.x","article-title":"High-dose intravenous immunoglobulin in non-ABO transfusion incompatibility","volume":"67","author":"Kohan","year":"1994","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2007.01.001_bib102","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1423-0410.1995.tb00373.x","article-title":"Post-transfusion hyperhaemolysis in a patient with sickle cell disease: Use of steroids and intravenous immunoglobulin to prevent further red cell destruction","volume":"69","author":"Cullis","year":"1995","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2007.01.001_bib103","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/08880019309029519","article-title":"High-dose intravenous immunoglobulin therapy, blood rheology, and sickle cell anemia","volume":"10","author":"Gangarossa","year":"1993","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib104","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1537-2995.2001.41030323.x","article-title":"Hyperhemolytic transfusion reaction in sickle cell disease","volume":"41","author":"Win","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2007.01.001_bib105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00867478","article-title":"The use of intravenous gammaglobulin in the treatment of typical hemolytic uremic syndrome","volume":"5","author":"Robson","year":"1991","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib106","first-page":"268","article-title":"High-dose intravenous gamma globulin infusions in hemolytic-uremic syndrome: A preliminary report","volume":"144","author":"Sheth","year":"1990","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.tmrv.2007.01.001_bib107","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000046567","article-title":"Efficacy of intravenous immunoglobulin in the treatment of thrombotic thrombocytopaenic purpura. A study of 44 cases","volume":"105","author":"Dervenoulas","year":"2001","journal-title":"Acta Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib108","first-page":"325","article-title":"Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP","volume":"80","author":"Centurioni","year":"1995","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2007.01.001_bib109","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ajh.2830410305","article-title":"Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura\/hemolytic-uremic syndrome","volume":"41","author":"Finazzi","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib110","doi-asserted-by":"crossref","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","article-title":"Heparin-induced thrombocytopenia: recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Warkentin","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.tmrv.2007.01.001_bib111","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1023\/A:1023238915316","article-title":"High-dose intravenous gamma-globulins for heparin-induced thrombocytopenia: A prompt response","volume":"18","author":"Winder","year":"1998","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib112","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ajh.2830390417","article-title":"Heparin-induced thrombocytopenia\u2014response to intravenous immunoglobulin in vivo and in vitro","volume":"39","author":"Grau","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib113","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/1120009X.1990.11739050","article-title":"Idiopathic thrombocytopenic purpura in HIV infection: therapeutic possibilities of intravenous immunoglobulins","volume":"2","author":"Perrella","year":"1990","journal-title":"J Chemother"},{"key":"10.1016\/j.tmrv.2007.01.001_bib114","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1537-2995.1994.34994378275.x","article-title":"An evaluation of intravenous immunoglobulin in the treatment of human immunodeficiency virus-associated thrombocytopenia","volume":"34","author":"Jahnke","year":"1994","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2007.01.001_bib115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1423-0410.1990.tb01637.x","article-title":"High-dose intravenous immunoglobulins in HIV-1\u2013infected adults with AIDS-related complex and Walter-Reed 5","volume":"59","author":"Schrappe-Bacher","year":"1990","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2007.01.001_bib116","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/08923979109019716","article-title":"Clinical and immunologic effects of combination therapy with intravenous immunoglobulins and AZT in HIV-infected patients","volume":"13","author":"De Simone","year":"1991","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib117","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/(SICI)1096-8652(199810)59:2<127::AID-AJH5>3.0.CO;2-#","article-title":"Usefulness of a low-dose intravenous immunoglobulin regimen for the treatment of thrombocytopenia associated with AIDS","volume":"59","author":"Majluf-Cruz","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib118","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-3476(05)80400-7","article-title":"A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura","volume":"123","author":"Blanchette","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.tmrv.2007.01.001_bib119","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(94)92205-5","article-title":"Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura","volume":"344","author":"Blanchette","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2007.01.001_bib120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/08880010252899370","article-title":"Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy","volume":"19","author":"Duru","year":"2002","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib121","first-page":"376","article-title":"A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura","volume":"72","author":"Fujisawa","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib122","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0140-6736(85)90400-3","article-title":"Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood","volume":"2","author":"Imbach","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2007.01.001_bib123","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000204392","article-title":"Idiopathic thrombocytopenic purpura in Egyptian children","volume":"90","author":"Khalifa","year":"1993","journal-title":"Acta Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib124","first-page":"169","article-title":"Treatment of acute idiopathic thrombocytopenic purpura (AITP): Cooperative Italian study group results","volume":"5","author":"Mori","year":"1988","journal-title":"Pediatric"},{"key":"10.1016\/j.tmrv.2007.01.001_bib125","first-page":"317","article-title":"Oral megadose methylprednisolone versus intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura","volume":"10","author":"Ozsoylu","year":"1993","journal-title":"Pediatric"},{"key":"10.1016\/j.tmrv.2007.01.001_bib126","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1651-2227.1996.tb14183.x","article-title":"Randomized trial comparing intravenous immunoglobulin with methylprednisolone pulse therapy in acute idiopathic thrombocytopenic purpura. Danish I.T.P. Study Group","volume":"85","author":"Rosthoj","year":"1996","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.tmrv.2007.01.001_bib127","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00043426-199705000-00004","article-title":"Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group","volume":"19","author":"Warrier","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib128","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3476(84)80455-2","article-title":"Fc-depleted vs intact intravenous immunoglobulin in chronic ITP","volume":"105","author":"Tovo","year":"1984","journal-title":"J Pediatr"},{"key":"10.1016\/j.tmrv.2007.01.001_bib129","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","article-title":"Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy","volume":"120","author":"British Committee for Standards in Haematology General Haematology Task Force","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib129a","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jpeds.2005.04.032","article-title":"Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: A systematic review and meta-analysis of randomized controlled trials","volume":"147","author":"Beck","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.tmrv.2007.01.001_bib130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Review","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.01.001_bib131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(02)07275-6","article-title":"Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: A randomised, multicentre trial","volume":"359","author":"Godeau","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2007.01.001_bib132","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/bmj.296.6617.249-a","article-title":"High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopenia","volume":"296","author":"von dem Borne","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.tmrv.2007.01.001_bib133","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/sj.thj.6200303","article-title":"Clinical efficacy and safety of a novel intravenous immunoglobulin preparation in adult chronic ITP","volume":"4","author":"Colovic","year":"2003","journal-title":"Hematol J"},{"key":"10.1016\/j.tmrv.2007.01.001_bib134","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.V82.5.1415.bloodjournal8251415","article-title":"Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin","volume":"82","author":"Godeau","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.01.001_bib135","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1365-2141.1999.01766.x","article-title":"Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: Results of a randomized trial comparing 0.5 and 1 g\/kg B.W.","volume":"107","author":"Godeau","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib136","first-page":"104","article-title":"Tolerability and efficacy of 5% versus 10% intravenous immunoglobulin preparation in adult patients with immune thrombocytopenia\u2014a pilot study","volume":"23","author":"Wehmeier","year":"1996","journal-title":"Infusionsther Transfusionsmed"},{"key":"10.1016\/j.tmrv.2007.01.001_bib137","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF00320256","article-title":"The comparison of gammaglobulin to steroids in treating adult immune thrombocytopenia. An interim analysis","volume":"59","author":"Jacobs","year":"1989","journal-title":"Blut"},{"key":"10.1016\/j.tmrv.2007.01.001_bib138","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00319544","article-title":"High-dose IgG for post-transfusion purpura\u2014revisited","volume":"57","author":"Mueller-Eckhardt","year":"1988","journal-title":"Blut"},{"key":"10.1016\/j.tmrv.2007.01.001_bib139","first-page":"1141","article-title":"Infection associated hemophagocytic syndrome: A report of 50 children","volume":"83","author":"Ningsanond","year":"2000","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.tmrv.2007.01.001_bib140","first-page":"998","article-title":"Childhood hemophagocytic syndrome associated with Kikuchi's disease","volume":"85","author":"Chen","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2007.01.001_bib141","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0022-3476(94)70336-1","article-title":"Treatment of infection-associated hemophagocytic syndrome with immune globulin","volume":"124","author":"Fort","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.tmrv.2007.01.001_bib142","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0022-3476(05)81761-5","article-title":"Intravenously administered immune globulin for the treatment of infection-associated hemophagocytic syndrome","volume":"123","author":"Freeman","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.tmrv.2007.01.001_bib143","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/adc.65.11.1275","article-title":"Intravenous immunoglobulin in virus associated haemophagocytic syndrome","volume":"65","author":"Goulder","year":"1990","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.tmrv.2007.01.001_bib144","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/BF02983819","article-title":"Hemophagocytic syndrome: An unusual manifestation of acute human immunodeficiency virus infection","volume":"78","author":"Chen","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib145","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2141.1994.tb05000.x","article-title":"High-dose gamma-globulin therapy in the reactive haemophagocytic syndrome","volume":"88","author":"Gill","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.01.001_bib146","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1212\/WNL.49.3.870","article-title":"Guillain-Barre and virus-associated hemophagocytic syndromes contracted simultaneously following Epstein-Barr viral infection","volume":"49","author":"Kaneko","year":"1997","journal-title":"Neurology"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796307000028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796307000028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T23:29:33Z","timestamp":1587425373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796307000028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":148,"alternative-id":["S0887796307000028"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2007.01.001","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}